SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-046746
Filing Date
2019-10-01
Accepted
2019-10-01 16:16:18
Documents
66
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv529974_10q.htm 10-Q 527159
2 EXHIBIT 10.46 tv529974_ex10-46.htm EX-10.46 17754
3 EXHIBIT 31.1 tv529974_ex31-1.htm EX-31.1 10574
4 EXHIBIT 31.2 tv529974_ex31-2.htm EX-31.2 10604
5 EXHIBIT 32.1 tv529974_ex32-1.htm EX-32.1 5216
  Complete submission text file 0001144204-19-046746.txt   4947583

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT acur-20190331.xml EX-101.INS 1250492
7 XBRL TAXONOMY EXTENSION SCHEMA acur-20190331.xsd EX-101.SCH 44101
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20190331_cal.xml EX-101.CAL 38539
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20190331_def.xml EX-101.DEF 173205
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20190331_lab.xml EX-101.LAB 325736
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20190331_pre.xml EX-101.PRE 314713
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10113 | Film No.: 191129301
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences